Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
19.78
+1.08 (5.78%)
At close: Apr 17, 2026, 4:00 PM EDT
19.95
+0.17 (0.84%)
After-hours: Apr 17, 2026, 7:48 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.58 billion as of April 17, 2026. Its market cap has increased by 483.47% in one year.
Market Cap
1.58B
Enterprise Value
1.24B
1-Year Change
483.47%
Ranking
Category
Stock Price
$19.78
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.58B, an increase of 87.23%. That is a compound annual growth rate of 13.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.58B | 55.01% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.59B |
| MBX Biosciences | 1.58B |
| Bicara Therapeutics | 1.57B |
| Iovance Biotherapeutics | 1.57B |
| Ardelyx | 1.54B |
| Biohaven | 1.51B |
| Viridian Therapeutics | 1.50B |
| AtaiBeckley | 1.49B |